Latest Funding Strategy News

Page 13 of 40
Elixir Energy has locked in a $10 million debt facility secured against its FY26 R&D tax refund to fund the Lorelle-3 appraisal well activities in Queensland’s Taroom Trough. This financial move aims to bolster working capital during a busy operational period.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.
Ada Torres
Ada Torres
20 Feb 2026
Talga Group’s application for a major Swedish government grant was declined due to budget constraints, yet the company remains on track with alternative financing to scale its graphite anode production.
Maxwell Dee
Maxwell Dee
19 Feb 2026
Caravel Minerals has secured non-binding Letters of Interest from Finnish and German export credit agencies, marking a significant step in financing its Caravel Copper Project. This European backing complements a diversified funding strategy as the company moves towards a Final Investment Decision.
Maxwell Dee
Maxwell Dee
19 Feb 2026
Austral Resources Australia has voluntarily suspended its shares on the ASX to complete a significant placement and secure a strategic investor commitment, with strong demand reported.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Empire Resources has successfully raised nearly $2.9 million through the first tranche of its planned $5 million placement, with a second tranche pending shareholder approval in March.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Stavely Minerals has locked in a $500,000 unsecured director loan facility to fund its 2026 Scoping Study targeting copper, gold, and silver production. This non-dilutive funding move underscores confidence from within the board as the company advances key projects.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.
Ada Torres
Ada Torres
17 Feb 2026
Kali Metals Limited has successfully raised approximately A$7 million through a Tranche 1 Placement, issuing over 38 million new shares at 18 cents each. This capital injection marks a significant step in the company’s funding strategy.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Malcolm Mines NL’s subsidiary has taken key steps towards establishing a 500,000 tonnes per annum gold processing facility at Leonora, signing critical agreements for technical and funding expertise.
Maxwell Dee
Maxwell Dee
11 Feb 2026
MEC Resources has successfully closed its Options Placement Offer, raising $359,162 through strong shareholder support. The fully subscribed offer sets the stage for the company’s next development phase.
Maxwell Dee
Maxwell Dee
9 Feb 2026
DGR Global has been flagged by ASX for breaching Listing Rule 10.1 after advancing $500,000 without prior shareholder approval. The company is now preparing to seek retroactive approval and address further funding tranches.
Maxwell Dee
Maxwell Dee
9 Feb 2026

Browse the archive

Full archive